EMA approves new tuberculosis drug delamanid
New drug, marketed by the Japanese company Otsuka, will be pivotal in improving treatment for drug-resistant forms of tuberculosis…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.